June 3, 2020 / 11:10 PM / a month ago

BRIEF-Acelrx Pharmaceuticals Announces It Will Not Further Revise Its Offer To Acquire Tetraphase

June 3 (Reuters) - Acelrx Pharmaceuticals Inc:

* ACELRX PHARMACEUTICALS ANNOUNCES IT WILL NOT FURTHER REVISE ITS OFFER TO ACQUIRE TETRAPHASE

* EXPECTS AGREEMENT TO BE TERMINATED BY TETRAPHASE

* ACELRX WILL BE PAID A BREAK-UP FEE OF APPROXIMATELY $1.8 MILLION

* CO-PROMOTION AGREEMENT BETWEEN ACELRX AND TETRAPHASE REMAINS IN PLACE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below